Here, lower maintenance doses of 3-5 mg, three times per week, sustained over months and cycled appropriately, may be more aligned with the goal than high-frequency maximum doses
Although significant progress in the development of immunotherapy over the past two decades (2), approximately 50% of IBD patients show response failure after initial advanced therapies, with response rates exhibiting a further decline for second- and third-line treatments (3, 4)
Neurochem Int 29: 121128
Using low-binding syringes can help, especially for expensive peptides where every microgram matters
(ref) Seiwerth S, Sikiric P, Grabarevic Z, Zoricic I, Hanzevacki M, Ljubanovic D, Coric V, Konjevoda P, Petek M, Rucman R, Turkovic B, Perovic D, Mikus D, Jandrijevic S, Medvidovic M, Tadic T, Romac B, Kos J, Peric J, Kolega Z
DOI: 10.3390/scipharm93020026, Wharton, S., Blevins, T., Connery, L., et al